Moneycontrol PRO

business

Buy Cipla, advises Sushil Kedia

Sushil Kedia of Dir-Quantitative Strategy, CIMB recommends buying Cipla within the pharma space. "One may see Hindustan Unilever rebounding by 10-15 percent from the current levels," he adds.

first published: Dec 14, 2013 01:15 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347